| Thanks to SoCalBio Weekly Update Sponsor |
Join us in June SoCalBio/Image 2000 Golf Classic
Title Sponsor
 Benefiting When: June 28, 2010Time: 10:00am - 8:30pm Where: Old Ranch Country Club, Seal Beach, California |
Join SoCalBioJoin well-known entrepreneur Alfred Mann and other SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth. |  |
|
|  Editor: Ahmed Enany
President & CEO
Southern California
Biomedical Council
(SoCalBio)
enany@socalbio.org
www.socalbio.org | May 3, 2010  |
|
Thanks to April 29 SoCalBio Vision Care Networking Forum's Speakers
From left: Sean Caffey (Replenish, Inc.), Rob Greenberg (Second Sight), Stacy Pritt (Biological Test Center), Chris Sandstedt (Calhoun Vision) and Paul Dougherty (Dougherty Laser Vision) |
Featured Study
| BIO and Battelle Release a New Report on the State of the Bioscience Industry in the U.S. During the BIO 2010 Convention in Chicago
The report -- entitled "State Bioscience Initiatives 2010" -- provides key statistics about the growth of the various sub-segments of the bioscience industry: drugs, devices, research/testing/medical laboratories, and ag/bio. The report's key funding is that the overall bioscience industry employment base has continued to grow even during the first year of the recession (2008)." This growth is attributable to the medical device industry and companies engaged in R&D and medical testing. The report is one of a kind because it provides regional profiles of the bioscience industry. One of the report's finding is that Los Angeles/Orange County and adjacent communities saw job growth from about 66,000 in 2004 to about 83,000 in 2008 (the last year for which data are currently available).... To get a PDF of this report, send email to SoCalBio |
Featured News Story
| Amgen Appoints Robert Bradway President and COO
 Amgen's Board of Directors appointed Robert A. Bradway president and chief operating officer (COO), effective May 11. In this new role, Bradway will report to Kevin Sharer, Amgen's chairman and chief executive officer, and will be responsible for the company's Global Commercial Operations, Manufacturing Operations, Strategy & Corporate Development, Information Technology, Global Government Affairs and Compliance... Read more
|
 | |
Upcoming SoCalBio Events
| May 6, 6:30 - 8:30 PM
SoCalBio Golf Tournament
Underwriters' Party
McCormick and Schmick's in Manhattan Beach
This free-for-SoCalBio-members celebration -- which will include hor d'oeuvres and drinks -- is graciously hosted by the National Multiple Sclerosis Society, Southern California Chapter. Don't miss this great networking opportunity.
Click here for invitation and to RSVP
May 28, 7:00 to 9:30 AM
SoCalBio Networking Forum in Orange County Navigating Healthcare ReformsUCI University Club in IrvineLearn from industry experts how the recently passed healthcare reform package can impact your business: from funding opportunities, changing reimbursement rules to the medical device tax. Click here to RSVPJune 10, 8:00 AM to 12:00 Noon
SoCalBio Open HouseWilshire Grand Hotel in Downtown Los Angeles Learn how SoCalBio's Group Purchasing Program can slow your company's burn rate and cut down the cost of doing business; and get detailed insight into how SoCalBio can help your organization succeed.Click here to RSVPJune 28, 10:00 AM - 8:30 PMSoCalBio/Image 2000 Golf Classic(ending with with reception and dinner)Old Ranch Country Club in Seal BeachJoin your medtech and biotech colleagues and friends for a great day of golf in one of the exquisite courses in Southern California while you show your support for the bioscience industry, the Multiple Sclerosis Society and SoCalBio.Click here to play, buy a foursome, or secure a tee sign |
|  |
From the Lab Bench
| Caltech Biologists Link Gut Microbial Equilibrium to Inflammatory Bowel Disease
 "It has been proposed that the coupled equilibrium between potentially harmful and potentially beneficial bacteria in the gut mediates health versus disease," says Sarkis K. Mazmanian, assistant professor of biology at Caltech. "If the balance is altered," say, by changes in diet, the effects of stress, or the use of antibiotics, "then the immune response in the intestines is also changed." This altered host-microbe relationship, called dysbiosis, has been linked to Inflammatory Bowel Disease and colon cancer as well as to obesity and diabetes.... Read more
|
| Financing | InTouch Technologies of Santa Barbara Raises $10 Million Through a Private Placement
InTouch Technologies, a provider of remote presence telemedicine solutions, has raised $10 million in new VC funding. Beringea led the round, and was joined by return backers Galen Partners, InvestCare Partners and Twenty One East Victoria..... Read more
|
| Regulatory | ImmunoCellular Therapeutics of Woodland Hills Files Orphan Drug Application for its Brain Cancer Vaccine
 "By harnessing the body's own immune system, ICT-107 (the company's dendritic-cell based brain cancer vaccine product) has been shown to keep glioblastoma patients free of disease for significantly longer than has been seen with current standard treatments," said Manish Singh, Ph.D. (photo right), ImmunoCellular Therapeutics' president and CEO. "We are applying for orphan drug status with the goal of advancing this promising cancer vaccine candidate to market as efficiently as possible."... Read more
|
M&As
| Valeant to Acquire Vital Science Corp. in Canada
Vital Science Corp. is an over-the-counter (OTC) dermatology company located in Toronto, Ontario, Canada. Valeant will pay approximately C$10.5 million for Vital Science which currently has annualized sales of approximately C$11 million .... Read more
|
Litigation
| Watson Pharmaceuticals Is Sued by Pfizer and Wyeth Pharmaceuticals Over Generic Version of Rapamune
Rapamune (sirolimus) tablets are indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving renal transplants. For the twelve months ending February 2010, RapamuneŽ had total U.S. sales of approximately $210.5 million according to IMS Health data. .... Read more
|
Personnel
| KYTHERA Biopharmaceuticals Appoints Industry Veteran Pierre Corin as Vice President, Global Clinical Operations
Pierre Corin brings more than 20 years of experience in clinical operations and management of large international trials, including specific expertise in aesthetic medicine. Pierre joins KYTHERA from Allergan Medical where he was the Director of Clinical Development and was responsible for the Silicone Breast Implant Follow-Up Study (BIFS). The BIFS study is the largest multinational post-approval study of its kind.... Read more
Arrowhead Research Announces the Appointment of Former FDA Commissioner and National Cancer Institute Director Dr. Andrew von Eschenbach to Its Board of Advisors
 "Dr. von Eschenbach (photo right) is a big addition to our team," said Arrowhead CEO, Dr. Christopher Anzalone. "He has a uniquely complete perspective on medicine, with deep understanding of science, the regulatory pathway, and healthcare delivery system. His active involvement at Arrowhead will be very powerful as we focus increasingly on nanomedicine" .... Read more
|
Jobs Available
| NeoMend (Irvine)
NeoMend, a wound-healing product company, is seeking to fill the following position: |
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
|
|
